An invasive management strategy is associated with improved outcomes in high‐risk acute coronary syndromes in patients with chronic kidney disease

Abstract

In patients with CKD after STEMI/NSTEACS, 6-month mortality and morbidity is high, selection for angiography is lower, yet angiography is associated with a reduced long-term mortality, and with comparable revascularization rates to those without CKD. In-hospital AKI is more common in CKD and predicts a high 6-month mortality.